Results 261 to 270 of about 707,804 (298)
Some of the next articles are maybe not open access.
Journal of Allergy and Clinical Immunology, 2003
During the past year, a number of reports have described HIV-1 superinfection in human subjects, defined as the reinfection of an individual with a second heterologous strain of HIV-1. These reports have challenged the assumption that HIV-1-specific immune responses generated during primary infection are protective against subsequent infection and have
Todd M, Allen, Marcus, Altfeld
openaire +2 more sources
During the past year, a number of reports have described HIV-1 superinfection in human subjects, defined as the reinfection of an individual with a second heterologous strain of HIV-1. These reports have challenged the assumption that HIV-1-specific immune responses generated during primary infection are protective against subsequent infection and have
Todd M, Allen, Marcus, Altfeld
openaire +2 more sources
Current Opinion in Infectious Diseases, 2012
This review describes the nature and frequency of HIV-1 superinfection and provides advice regarding counselling of patients in accordance with national guidelines.Recent studies have demonstrated conflicting results, from no superinfection to an incidence of over 18%.
Laura, Waters, Erasmus, Smit
openaire +2 more sources
This review describes the nature and frequency of HIV-1 superinfection and provides advice regarding counselling of patients in accordance with national guidelines.Recent studies have demonstrated conflicting results, from no superinfection to an incidence of over 18%.
Laura, Waters, Erasmus, Smit
openaire +2 more sources
Biomarkers in Medicine, 2007
104bLB. 32. Nelson M, Fatkenheuer G, Konourina I et al.: Efficacy and safety of maraviroc plus optimised background therapy in viremic ART-experienced patients infected with CCR5-tropic HIV-1 in Europe, Australia and North America: 24 week results. Presented at: 14th Conference on Retroviruses and Opportunistic Infections.
George, Panos, Mark, Nelson
openaire +2 more sources
104bLB. 32. Nelson M, Fatkenheuer G, Konourina I et al.: Efficacy and safety of maraviroc plus optimised background therapy in viremic ART-experienced patients infected with CCR5-tropic HIV-1 in Europe, Australia and North America: 24 week results. Presented at: 14th Conference on Retroviruses and Opportunistic Infections.
George, Panos, Mark, Nelson
openaire +2 more sources
Science, 2021
Structural transformation of HIV-1 matrix during virus maturation promotes ...
Yuta, Hikichi, Eric O, Freed
openaire +2 more sources
Structural transformation of HIV-1 matrix during virus maturation promotes ...
Yuta, Hikichi, Eric O, Freed
openaire +2 more sources
HIV-1–specific CTLs effectively suppress replication of HIV-1 in HIV-1–infected macrophages
Blood, 2007AbstractBoth CD4+ T cells and macrophages are major reservoirs of HIV-1. Previous study showed that HIV-1–specific cytolytic T lymphocytes (CTLs) hardly recognize HIV-1–infected CD4+ T cells because of Nef-mediated HLA class I down-regulation, suggesting that HIV-1 escapes from HIV-1–specific CTLs and continues to replicate in HIV-1–infected donors. On
Mamoru, Fujiwara, Masafumi, Takiguchi
openaire +2 more sources